Fibrocell Science, Inc. Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2019-09-30..
Operating margin
Overview →Financial period ending 2019-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 2.12M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 4.72M USD | Research and Development Expense |
| Selling, general and administration | 8.96M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2019-09-30 | $2.12M | (m) | (m) | $4.72M | $8.96M | (m) |
| 2019-06-30 | $3.38M | (m) | (m) | $5.50M | $7.54M | (m) |
| 2019-03-31 | $-13.27M | $0.00 | (m) | $6.32M | $6.64M | (m) |
| 2018-12-31 | $-12.39M | $0.00 | (m) | $6.02M | $6.41M | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $-17.51M | $0.00 | (m) | $6.69M | $6.91M | (m) |
| 2017-12-31 | $-18.98M | $0.00 | (m) | $6.51M | $6.75M | (m) |
| 2017-09-30 | $-18.55M | $37.00K | (m) | $6.60M | $6.88M | -50140.54% |
| 2017-06-30 | $-18.97M | $252.00K | (m) | $6.59M | $7.64M | -7528.97% |
| 2017-03-31 | $-24.27M | $339.00K | (m) | $7.26M | $8.51M | -7157.82% |
| 2016-12-31 | $-26.48M | $355.00K | (m) | $8.40M | $9.77M | -7458.87% |
| 2016-09-30 | $-38.37M | $400.00K | (m) | $9.36M | $10.25M | -9591.25% |
| 2016-06-30 | $-40.17M | $264.00K | (m) | $10.11M | $10.00M | -15216.29% |
| 2016-03-31 | $-37.21M | $314.00K | (m) | $10.32M | $11.10M | -11850.64% |
| 2015-12-31 | $-37.41M | $492.00K | (m) | $9.97M | $11.29M | -7603.05% |
| 2015-09-30 | $-27.21M | $466.00K | (m) | $1.64M | $10.98M | -5839.70% |
| 2015-06-30 | $-26.58M | $407.00K | (m) | $2.32M | $11.13M | -6530.96% |
| 2015-03-31 | $-25.82M | $328.00K | (m) | $2.67M | $10.67M | -7871.34% |
| 2014-12-31 | $-29.95M | $180.00K | (m) | $8.34M | $10.09M | -16641.11% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-30.50M | $200.00K | (m) | $3.64M | $9.44M | -15251.50% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-29.39M | (m) | (m) | $10.19M | $11.55M | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $-19.98M | (m) | (m) | $7.17M | $12.79M | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.